The HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a simple, widely used mathematical index to estimate insulin resistance from routine blood tests. It is not a direct lab test but a calculation based on fasting blood glucose and fasting insulin levels.
It helps detect early insulin resistance, which is a key driver of prediabetes, type 2 diabetes, fatty liver (MASLD), metabolic syndrome, PCOS, and related conditions—especially relevant in India where these issues are rising rapidly.
- You need to be fasting for at least 8–12 hours (usually overnight).
- A blood sample is drawn to measure:
- Fasting plasma glucose (in mg/dL or mmol/L)
- Fasting insulin (in μU/mL or μIU/mL)
- No special preparation beyond fasting; it's often done alongside routine sugar tests.
- Most widely used (SI units, common internationally and in many Indian labs):
HOMA-IR = (Fasting insulin [μU/mL] × Fasting glucose [mmol/L]) ÷ 22.5 - US/common alternative (when glucose is in mg/dL):
HOMA-IR = (Fasting insulin [μU/mL] × Fasting glucose [mg/dL]) ÷ 405(To convert glucose: mg/dL ÷ 18 = mmol/L)
- Fasting glucose = 95 mg/dL (≈ 5.28 mmol/L)
- Fasting insulin = 12 μU/mL
Using US formula: (12 × 95) ÷ 405 ≈ 2.81
This suggests moderate insulin resistance.
- < 1.0 → Optimal insulin sensitivity (very good)
- < 1.5–2.0 → Normal/healthy range (most people without issues fall here)
- 1.9–2.5 → Early/mild insulin resistance (warrants lifestyle attention)
- > 2.5 → Significant insulin resistance (common threshold in many studies, including NHANES data)
- > 2.9–3.0 → Marked/severe resistance (higher risk of progression to diabetes, fatty liver, etc.)
- Many studies suggest cutoffs around 2.0–2.5 for identifying insulin resistance or metabolic syndrome.
- Some South Indian studies propose lower cutoffs like 1.23–2.5 depending on the group (adults vs. adolescents, urban vs. rural).
- Values >2.5 are frequently flagged as abnormal in Indian clinical practice for early intervention.
- Increased risk of fatty liver progression
- Higher chance of developing type 2 diabetes
- Features like acanthosis nigricans, central obesity, high triglycerides
- HOMA-IR is inexpensive and practical but less accurate in advanced diabetes (when beta cells fail and insulin drops) or extreme obesity.
- It reflects hepatic insulin resistance well but is not perfect for peripheral (muscle) resistance.
- Best used with other markers: fasting insulin alone (>10–12 μU/mL often concerning), HbA1c, lipid profile, liver enzymes, or OGTT for confirmation.
- In the context of fatty liver discussions , HOMA-IR is a quick, non-invasive way to spot insulin resistance early—before glucose rises.
Comments
Post a Comment